Your browser doesn't support javascript.
loading
Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing.
Floyd, James S; Bloch, Katarzyna M; Brody, Jennifer A; Maroteau, Cyrielle; Siddiqui, Moneeza K; Gregory, Richard; Carr, Daniel F; Molokhia, Mariam; Liu, Xiaoming; Bis, Joshua C; Ahmed, Ammar; Liu, Xuan; Hallberg, Pär; Yue, Qun-Ying; Magnusson, Patrik K E; Brisson, Diane; Wiggins, Kerri L; Morrison, Alanna C; Khoury, Etienne; McKeigue, Paul; Stricker, Bruno H; Lapeyre-Mestre, Maryse; Heckbert, Susan R; Gallagher, Arlene M; Chinoy, Hector; Gibbs, Richard A; Bondon-Guitton, Emmanuelle; Tracy, Russell; Boerwinkle, Eric; Gaudet, Daniel; Conforti, Anita; van Staa, Tjeerd; Sitlani, Colleen M; Rice, Kenneth M; Maitland-van der Zee, Anke-Hilse; Wadelius, Mia; Morris, Andrew P; Pirmohamed, Munir; Palmer, Colin A N; Psaty, Bruce M; Alfirevic, Ana.
Afiliação
  • Floyd JS; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Bloch KM; MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
  • Brody JA; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Maroteau C; Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom.
  • Siddiqui MK; Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom.
  • Gregory R; Functional and Comparative Genomics, Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
  • Carr DF; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Molokhia M; School of Population Health and Environmental Sciences, London, United Kingdom.
  • Liu X; Human Genetics Center, University of Texas Health Science Center, Houston, United States of America.
  • Bis JC; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Ahmed A; Medical School, University of Liverpool, Liverpool, United Kingdom.
  • Liu X; Functional and Comparative Genomics, Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
  • Hallberg P; Department of Medical Sciences, Clinical Pharmacology and Science for Life Laboratory, Uppsala University, Uppsala University Hospital, Uppsala, Sweden.
  • Yue QY; Medical Products Agency, Uppsala, Sweden.
  • Magnusson PKE; Swedish Twin Registry, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Brisson D; Clinical Lipidology and Rare Lipid Disorders Unit, Department of Medicine, Université de Montréal Community Gene Medicine Center, Lipid Clinic Chicoutimi Hospital and ECOGENE-21 Clinical and Translational Research Center, Chicoutimi, Quebec, Canada.
  • Wiggins KL; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Morrison AC; Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, United States of America.
  • Khoury E; Clinical Lipidology and Rare Lipid Disorders Unit, Department of Medicine, Université de Montréal Community Gene Medicine Center, Lipid Clinic Chicoutimi Hospital and ECOGENE-21 Clinical and Translational Research Center, Chicoutimi, Quebec, Canada.
  • McKeigue P; Usher Institute of Population Health Sciences and Informatics, University of Edinburgh Medical School, Edinburgh, Scotland, United Kingdom.
  • Stricker BH; Department of Epidemiology, Erasmus Medical Centre, Rotterdam, the Netherlands.
  • Lapeyre-Mestre M; Paul Sabatier University - Toulouse III, UPS Toulouse, Laboratoire de Pharmacologie Medicale et Clinique, Toulouse, France.
  • Heckbert SR; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.
  • Gallagher AM; Clinical Practice Research Datalink (CPRD) Medicines and Healthcare Products Regulatory Agency, London, United Kingdom.
  • Chinoy H; Rheumatology Department, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Salford, United Kingdom.
  • Gibbs RA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, United States of America.
  • Bondon-Guitton E; Centre Hospitalier Universitaire de Toulouse, CHU Toulouse, Centre de Pharmacovigilance, Toulouse, France.
  • Tracy R; Departments of Pathology & Laboratory Medicine and Biochemistry, Larner College of Medicine, University of Vermont, Burlington, Vermont, United States of America.
  • Boerwinkle E; Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, United States of America.
  • Gaudet D; Clinical Lipidology and Rare Lipid Disorders Unit, Department of Medicine, Université de Montréal Community Gene Medicine Center, Lipid Clinic Chicoutimi Hospital and ECOGENE-21 Clinical and Translational Research Center, Chicoutimi, Quebec, Canada.
  • Conforti A; U.O. Farmacologia, Policlinico "Gb Rossi", Verona, Italy.
  • van Staa T; Division of Informatics, Imaging & Data Sciences, University of Manchester, Manchester, United Kingdom.
  • Sitlani CM; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Rice KM; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America.
  • Maitland-van der Zee AH; Respiratory Medicine/Pediatric Respiratory Medicine, AMC, Amsterdam, the Netherlands.
  • Wadelius M; Medical School, University of Liverpool, Liverpool, United Kingdom.
  • Morris AP; Department of Biostatistics, University of Liverpool, Liverpool, United Kingdom.
  • Pirmohamed M; MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
  • Palmer CAN; Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom.
  • Psaty BM; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Alfirevic A; MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom.
PLoS One ; 14(6): e0218115, 2019.
Article em En | MEDLINE | ID: mdl-31242253
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rabdomiólise / Músculo Esquelético / Inibidores de Hidroximetilglutaril-CoA Redutases / Sequenciamento Completo do Genoma Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rabdomiólise / Músculo Esquelético / Inibidores de Hidroximetilglutaril-CoA Redutases / Sequenciamento Completo do Genoma Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos